PharmaRemeGen Lands $5.6 Bn Deal – Why Bispecific Antibody Technology Keeps Drawing Multinational Giants
ConsumptionSunny & Sandy Aims for Hong Kong Listing with Low-Cost IP Toys, Targeting Lower-Tier Markets
ConsumptionHuiyuan Group Declares Restructuring Failure, Moves to Retake Control of Huiyuan Brand Amid Dispute with Investor
Real EstateYu Liang Resigns as China Vanke’s Director and Executive Vice President, Quietly Withdraws from Core Management Over Past Year
ConsumptionPop Mart Expands Global Production Amid Labubu Craze, Partner Factories in Southeast Asia and Mexico Begin Shipping
InternetAmap Continues to Ramp Up In-Store Business, Upgrades AMAP Street Stars with “Flying Street View”
PharmaChina’s Innovative Drug BD Deal Value More than Doubles to Hit New Record in 2025 – What’s Ahead in 2026?